PRRT2 and breast carcinoma: In other breast cancer cell lines, it signals via a Par2—phospholipase C γ2 (PLCγ2)—protein kinase C (PKC) pathway, resulting in the upregulation of NFkB and subsequent mmp9 expression responsible for metastasis [49].